Clinical Trials
4 trialsNCT05300048 2026-04-30
Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations
Faeth Therapeutics
Phase 1 Terminated
NCT01899053 2019-10-30
A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies
Takeda
Phase 1 Completed
NCT02625259 2018-01-08
A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants
Takeda
Phase 1 Completed
NCT01449370 2017-03-09
Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer
Takeda
Phase 1 Completed